Abstract
C-terminus of Hsc/p70-Interacting Protein (CHIP) is a homodimeric E3 ubiquitin ligase. Each CHIP monomer consists of a tetratricopeptide-repeat (TPR), helix-turn-helix (HH), and U-box domain. In contrast to nearly all homodimeric proteins, CHIP is asymmetric. To uncover the origins of asymmetry, we performed molecular dynamics simulations of dimer assembly. We determined that a CHIP monomer is most stable when the HH domain has an extended helix that supports intra-monomer TPR-U-box interaction, blocking the E2-binding surface of the U-box. We also discovered that monomers first dimerize symmetrically through their HH domains, which then triggers U-box dimerization. This brings the extended helices into close proximity, including a repulsive stretch of positively charged residues. Unable to smoothly unwind, this conflict bends the helices until the helix of one protomer breaks to relieve the repulsion. The abrupt snapping of the helix forces the C-terminal residues of the other protomer to disrupt that protomer’s TPR-U-box tight binding interface, swiftly exposing and activating one of the E2 binding sites. Mutagenesis and biochemical experiments confirm that C-terminal residues are necessary both to maintain CHIP stability and function. This novel mechanism indicates how a ubiquitin ligase maintains an inactive monomeric form that rapidly activates only after asymmetric assembly.
Introduction
Generally, the lowest energy state of protein assembly is symmetrical, whereas asymmetry is associated with energy frustration and structural instability1. However, symmetry is not evolutionarily constrained, and many oligomeric enzymes are known to be asymmetric with only half-of-sites active2–5. In the majority of such oligomers, asymmetry results from conformational changes triggered by ligand binding2, 6, 7. Another mechanism to fold and activate asymmetric dimers requires that one of the ligand-binding sites is deformed3, 6, 7. However, very few of the vast number of known homo-multimeric proteins assemble into asymmetric structures6. Among the exceptions are the C-terminus of Hsc/p70-Interacting Protein (CHIP)8, an E3 ubiquitin ligase that associates with cyoplasmic Hsp70 and Hsp90 chaperones, and Hikeshi9, a nuclear import protein that also binds Hsp70. Unveiling the mechanism of symmetry breaking in homo-oligomers will shed light on new principles of folding and assembly for this important class of proteins.
The CHIP homodimer consists of three domains: tetratricopeptide repeat (TPR), helix-turn-helix (HH), and U-box8 (Fig. 1). CHIP targets misfolded, chaperone-bound substrates for proteasomal degradation by transferring ubiquitin from a compatible E2 ubiquitin conjugating-enzyme, which associates with the U-box domain, to a lysine residue on the target protein10, 11. The crystal structure of murine CHIP (CHIP, PDB: 2C2L), which differs from human CHIP by one residue at the N-terminus, showcases an asymmetric homodimer in which only one U-box domain has an accessible E2-binding surface. The E2 binding site/U-box in the second protomer is blocked by intra-protomer packing against the TPR domain8 (Fig. 1). In this second protomer, the HH domain is bent, whereas the HH domain of the first protomer is extended. This pronounced asymmetry contrasts strongly with the symmetric structure of a Zebrafish CHIP construct (fCHIP, PDB: 2F42) from which the TPR domain is deleted12 (Fig. 1).
CHIP plays essential roles in modulation of the stress response, protein quality control, innate immune signaling, neurodegenerative disorders, and cancer progression13–20. In addition to revealing general assembly principles of asymmetric heterodimerization, a definition of the CHIP folding pathway may uncover the nature of disease-causing mutations in this critical proteostasis component (see e.g. ref. 21) and inform the development of small molecule therapeutics. Here, we describe for the first time the origin of symmetry breaking in homodimerization. We define the CHIP dimer assembly pathway using full atom molecular dynamics simulations (MDS), site-directed mutagenesis, and biochemical studies. Our analyses indicate that the CHIP monomer is most stable when the HH domain has an extended helix that supports domain-domain interaction between the U-box and TPR, which blocks the E2-binding site. Activation requires that this interaction be disrupted in at least one protomer of the CHIP dimer. We reveal how the assembly of the asymmetric dimer leads to kinetic (rather than thermodynamic) disruption of U-box and TPR domain packing in one of the protomers, which exposes the E2 binding site. Specifically, two monomers initially dimerize symmetrically through their HH domains. This initial assembly event triggers U-box dimerization, which unites positively charged residues from the linker regions between the U-box and the HH domains of each protomer. In turn, this repulsion is resolved by breaking a helix in one of the protomers. This action forces the opposite protomer to wedge its C-terminal through its own TPR and U-box domain-domain interface in tens of nanoseconds, forming a stable asymmetric CHIP dimer8. We also confirmed that in the absence of the TPR domain, CHIP folds into a symmetric structure, as observed in the crystal structure of CHIP lacking the TPR domain12. Simulations, enzyme activity assays, and biophysical methods further validate that a short C-terminal segment plays a critical role in stabilizing the active, asymmetric CHIP dimer. Our findings describe a novel assembly mechanism that transduces the snapping of a helix into a mechanical force that kinetically activates the CHIP dimer by disrupting a stable domain-domain interaction. This model delineates how a ligand- and chaperone-dependent ubiquitin ligase is maintained in an inactive monomeric form that is rapidly activated only after assembly.
Results
U-box-TPR interdomain packing is favored in the CHIP monomer
Crystallographic studies show that full-length murine CHIP (“CHIP”) forms an asymmetric dimer8 (Fig. 1). In one of the protomers (referred to as “bent”), the HH domain and TPR-U-box complex are separated by a broken helix 7 (H7). In this protomer configuration, a tight interface formed by the U-box and TPR domains obscures the E2 binding site (Fig. 2A). In the other protomer (referred to as “straight”) H7 is extended and contiguous with the TPR domain, which is separated from the U-box domain by the protomer’s C-terminus. The E2 binding site of the U-box is surface-exposed and accessible in this protomer (Fig. 2B).
To gain insight into the structures of monomeric CHIP, we ran MDS of isolated bent and straight monomers in explicit solvent. Simulations of the bent monomer show that packing between the TPR and U-box domains remains stable (Fig. 2D) and H7 is capable of sampling an extended helix connected to the HH domain, similar to the straight monomer (Fig. 2E). Simulations of the straight monomer show that the extended H7 is maintained (Fig. 2E), and the C-terminus remains inserted between the U-box and TPR domains throughout (Fig. 2D).
To further investigate the stability of the straight monomer, we deleted its six C-terminal residues and performed MDS of the truncation, CHIP23–297. In the absence of the C-terminal residues, H7 is stable. However, a domain-domain interaction between the TPR and U-box can form and assumes a conformation similar to that of the bent monomer of the asymmetric CHIP dimer (Fig. 2D,E). The stability of the chimeric structure formed by the truncated straight CHIP23–297 (Fig. 2C) was further examined in full length (minus disordered N-terminal) CHIP23–303. Interestingly, this chimera combines the stable domains from each monomeric structure, i.e., the extended helix from the straight monomer and the TPR-U-box complex from the bent monomer. Our simulations show that the chimeric monomer is more stable than either the straight or bent monomer (Fig. 2D,E), and is readily sampled by both the bent monomer and the truncated straight monomer (Fig. 2C). Folding free energy calculations using MM/PBSA22 further support our conclusion that the chimera is the most stable monomeric structure (Supplementary Fig. S1).
Models of nucleation events during CHIP dimerization
While the structure of the CHIP dimer is asymmetric overall, the HH and U-box dimers within this structure are symmetric (Fig. 1). Computational estimates23 suggest that the HH and U-box dimerization interfaces have similar interaction energies (ΔGint) of −15.2 and −14.4 kcal/mol, respectively. The HH dimer is relatively rigid and dominated by hydrophobic interactions (the hydropobic-polar residues ratio is ~2:1), whereas the U-box dimer is more flexible and mediated primarily by electrostatic interactions (hydropobic-polar residues ratio is ~1:1). We did not observe interconversions between the bent and straight monomers within the time scale of our simulations. Such interconversions are expected to be quite slow, since large thermal fluctuations are required to disrupt TPR-U-box packing in the bent monomer (interaction energy estimate ΔGint = −20 kcal/mol23). This suggests that the dimer asymmetry arises through an induced-fit process initiated by dimer formation. To test this idea, we built two different dimeric assemblies for the bent, straight, and chimeric monomer models, employing either “HH-dimer-first” or “U-box-dimer-first” dimerization modes.
As shown in Fig. 3A (top), the HH-dimer-first models allow dimerization without steric clash. On the other hand, the HH domains clash in all three U-box-dimer-first models (Fig. 3A, bottom). Although the chimeric model shows the lowest degree of steric clash, the HH domains assemble incorrectly and expose their true dimerization interfaces to solvent. Based on this analysis and the expectation that the large hydrophobic patches of the HH domains provide a natural path for dimerization, we conclude that CHIP dimerization begins with HH dimer nucleation. It is interesting to note that a symmetric dimer formed by the two bent or chimeric monomers would be inactive, whereas a dimer formed by straight monomers may, in principle, bind two E2s.
Can symmetric nucleation lead to an asymmetric dimer?
We next performed full atom unconstrained MDS in explicit solvent starting from each of three HH-dimer-first models shown in Fig. 3A. A representative snapshot of the resulting structures is shown in Supplementary Fig. S2. For the HH-bent-dimer model, the simulations indicate that the U-boxes dimerize on a time scale of >50 ns (Fig. 3B) and TPR-U-box domain packing remains stable in both protomers (Fig. 3D). Moreover, no extended H7 helix, as observed in the straight protomer of the CHIP crystal structure, forms in either protomer (Fig. 3C). The structure remains rather symmetric but flexible between the HH dimer and the TPR-bound U-box dimer. In the case of the HH-straight-dimer, the U-boxes do not dimerize during the simulation (Fig. 3B). Correspondingly, the TPRs remain co-axial with the extended helices (Fig. 3C) and do not interact with the U-boxes (Fig. 3D). This dimer is also relatively symmetric with flexible U-boxes that are separated from the TPRs by the C-terminus of each protomer. To test whether C-terminus insertion significantly slows down further structural rearrangements, we truncated the six C-terminal residues but found that the U-boxes still failed to dimerize. Within the time scale of our MDS, the straight helices allow little freedom for the U-boxes to properly accommodate a U-box dimer interface. Instead, a partial rotation moves the E2 binding sites into close proximity.
Finally, we simulated an HH-chimeric-dimer model in which the U-boxes are separated by more than 10 Å in the starting conformation. In these simulations, the U-boxes dimerize properly (Fig. 3B). Moreover, the extended H7 breaks in protomer 2 (see Fig. 3C), and the TPR-U-box complex is forcibly separated due to insertion of the C-terminal residues in protomer 1 (Fig. 3D). In principle, all pathways are allowed during CHIP dimerization, yet our simulations strongly suggest that not only the chimeric monomer and HH-chimeric-dimer model are more stable but also they are the kinetically favored path between a stable monomer and the asymmetric dimer. In contrast, in all other models tested (Supplementary Fig. S2) folding stalled in a symmetric structure. It should be noted that our longest MDS are about 600 ns, but that millisecond- or longer simulations may be required for these less likely initial configurations to progress towards the asymmetric dimer structure.
Fast dissociation kinetics of TPR-U-box complex by the C-terminus is driven by U-box dimerization
Starting from the symmetric HH-chimeric-dimer model, the transformation to the asymmetric structure follows a four-stage kinetic process driven by U-box dimerization. Namely, (a) rapid partial symmetric U-box dimerization is followed by (b) breaking of the extended helix in one protomer (i.e., breaking dimer symmetry), which leads to (c) the insertion of C-terminal residues into the U-box-TPR binding interface in the other protomer, and then (d) the partial U-box dimer assumes a native-like conformation. The resulting asymmetric dimer is in good agreement with the full CHIP crystal structure, yielding an overall backbone RMSD of 4.9 Å. The dynamics of this process is presented in Fig. 4.
Our MDS show that HH-domain dimerization in the chimeric model positions the U-boxes within interaction range, triggering their dimerization. In a fast time scale of ~20 ns, the U-boxes change from an RMSD of ~12 Å to ~6.0 Å relative to the U-box dimer in the CHIP crystal structure. However, since the U-boxes are bound to their corresponding TPRs, the dimers at both end of the long helices prevent the unwinding of the helices. Instead, dimerization brings together five consecutive basic amino acids (221KRKKR227) in the linker between the HH and U-box domains from each protomer. These basic sequences initially help to drive dimerization by interacting with U-box residues E297 and N298. However, the repulsive interactions of the positively charged linker residues eventually start leaning against 153RRIH158 in H7, bending the extended helices. Ultimately, the electrostatic repulsion is relieved by breaking H7 of one protomer at this site in <50 ns (Fig. 4A,C). Partly due to interactions between the opposite linker and C-terminal negative charges (301EDY), the snapping of the helix forces the insertion of the C-terminus between the U-box and the TPR domain in the opposite protomer. This process takes about 40 ns, i.e., between 50 and 90 ns from the beginning of the simulation (Fig. 4A,D). Interestingly, it is not until all the stress created by the opposing interactions and helix breaking has relaxed and the asymmetry is established that U-box dimerization proceeds towards a high affinity complex between 90 and 120 ns (Fig. 4A,B).
Deletion of the TPR domain leads to a symmetric CHIP structure
The crystal structure of a Zebrafish CHIP construct (fCHIP) that lacks TPR domains (Fig. 1), is symmetric12, whereas full-length CHIP is asymmetric8. To determine whether our model predicts the formation of a symmetric dimer if the TPR domains are removed, we re-ran the HH-chimeric-dimer model with CHIP lacking residues 1–145. As expected, CHIP146–303 dimerized into a symmetric structure closely resembling the fCHIP crystal structure (Fig. 5A). The formation of this structure was guided by the same linker interactions described above. However, in the absence of the TPR domain the extended helices are free. Thus, the repulsive charges in the linker are not forced together and the U-boxes dimerize in ~50 ns (Fig. 5A).
Removal of the C-terminus disrupts CHIP folding
We next performed MDS using a truncated form of CHIP, CHIP23–297, in which the six C-terminal residues were deleted. In these simulations, the dimerization process stalls after the U-boxes recapitulate fast recognition of the dimer interfaces observed in full-length CHIP (Fig. 6A). The truncated C-terminus no longer acts as a wedge, and the U-box-TPR interface is not disrupted within the time scale of our simulations (Fig. 6B). Instead, H7 is broken and attains a state that affords little room for the U-box recognition state to proceed toward the high affinity U-box dimer (inset Fig. 6A). Interestingly, this state tends to “lock in” a symmetric structure, which resembles the HH-bent-dimer and HH-straight-dimer models (see Supplementary Fig. S2).
Based on our simulations, the C-terminus plays a critical role in CHIP folding. We therefore expressed and purified a human CHIP construct lacking the six C-terminal amino acids, CHIP1–297. When compared to the purified full-length protein in thermal unfolding assays that measure SYPRO dye binding (thermofluor), the truncation mutant was destabilized by ~12.5 °C compared to full-length CHIP (Fig. 6C). These data are consistent with other reports on the relative thermal stability of wild type CHIP24, as well as the weakened U-box dimer interaction observed in our MDS when the C-terminus is truncated (Fig. 6A). A defect in the overall conformation was further evidenced by the decreased stability of the mutant protein in a limited proteolysis assay (Fig. 6D). To determine whether CHIP1–297 was substantially or fully unfolded, we compared circular dichroism (CD) spectra of CHIP1–297 to those of full-length CHIP. Consistent with the observed breaking of both H7 (see inset Fig. 6A), the CD spectra (Supplementary Fig. S3) show that CHIP1–297 contains substantial secondary structure content, but the calculated α-helical content is less than that of the full-length protein. In addition, the thermal transition in the overall structure of CHIP1–297 is not reflected in the temperature dependence of secondary structure content (Supplementary Fig. S3E). In other words, the transition at ~25 °C likely represents a loosening of the tertiary structure and disruption of the relative arrangement of domains within the dimer.
As the truncated protein appears to be more labile than full-length CHIP, we examined whether CHIP1–297 is catalytically active. Full-length and truncated forms of CHIP were incubated in a reaction containing E1, E2, ATP, ubiquitin, and a model substrate, the C-terminal client-binding domain of Hsc70 (Hsc70395–646; see Supplementary Methods). As shown in Fig. 6E, substrate ubiquitination was significantly abrogated in a reaction containing CHIP1–297, and CHIP1–297 auto-ubiquitination activity was absent. Together, these data support a critical role for the C-terminal residues in CHIP folding, dimerization, and stabilization.
Discussion
The folding/binding pathway leading to an asymmetric dimer between identical proteins must overcome competing interactions. During the formation of such dimers, an intermolecular interaction between, for example, residue Aprot1 and residue Bprot2 is not duplicated between Aprot2 and Bprot1. Instead, protomer 2 must make distinct favorable contacts different from those of protomer 1. One might expect that overall dimer stability would suffer as a consequence of this frustrated landscape. Here, we report how this conundrum is resolved and describe for the first time an origin of symmetry breaking during the formation of a stable homodimer.
We first analyzed the stability of individual CHIP monomers (Fig. 2). The straight monomer exhibits a stable H7 helix and a rather flexible U-box, while the bent monomer exhibits a broken H7 and a stable TPR-U-box interaction. Intriguingly, a chimeric structure that combined the former (stable) H7 and the latter (interacting) TPR-U-box domains was more stable than either of the other two configurations. Although the structure of an isolated CHIP monomer has not been determined, Nikolay et al.25 showed that a chimeric dimer between a full-length CHIP monomer and an HH domain lacked ubiquitination activity. This finding is consistent with our predicted chimeric structure, in which the E2 binding site of the U-box is buried by the TPR domain. These data suggest that a CHIP monomer is inactive.
Two inactive monomers dimerize and undergo a series of conformational changes into a half-of-sites active dimer (see Supplemetary Video S1). We show that the most likely path to initiate CHIP dimerization is via the hydrophobic HH dimer interface (Fig. 3). Further validating our predicted structure of the chimeric monomer, we established that the HH dimer positions the U-box dimerization interfaces within interaction range, optimizing the assembly process. Namely, MDS demonstrate that in a time scale of ~150 ns (Fig. 4) U-box dimerization triggers symmetry breaking of the dimer and disrupts one of the TPR-U-box complexes. The latter event exposes an E2 binding site, resulting in a ligase competent to ubiquitinate exogenous substrates.
The TPR-U-box interactions that also involve some contacts with H7 are predicted to be stronger than those within the individual dimer interfaces, ΔGint = −20 kcal/mol23. This presumes that the TPR and U-box might have a dissociation time scale of milliseconds or longer. Strikingly, the novel symmetry breaking mechanism uncovered in this report would instead disrupt this interface in <100 ns (Fig. 4). Following the formation of an HH-chimeric-dimer, the U-boxes start to dimerize and in ~20 ns they reach a low free energy “recognition” state. This state is a prelude to the more subtle structural rearrangements that form the higher affinity U-box dimer present in CHIP crystal structures. U-box-U-box interaction drives the extended HH helices together, which push against the positively charged linker (221KRKKR227) situated between the TPR and HH domains. It is important to note that the helices are held at both ends by the HH and U-box dimers, which prevents the smooth unwinding of the helices. Instead, repulsive interactions between the linkers and 153RRIH158 in H7 eventually snap one of the extended helices at this site. This motion wedges the C-terminus of the other protomer against the binding interface of the corresponding TPR and U-box domains, splitting the complex in ~100 ns. It is only after these transitions are completed and the structure is relieved of competing interactions that U-box dimerization process can proceed.
Our data suggest that the binding free energy of the partial U-box dimer provides a reservoir to resolve conflicting interactions in the linker regions and occlusion of the E2 binding sites by the TPR domains (Fig. 5B). Such interactions present a barrier in the U-box dimerization pathway. Instead of letting thermodynamics (i.e., large thermal fluctuations) control the activation of CHIP, we show for the first time that opposing interactions can generate a force that leads to the kinetic control of conformational activation (Fig. 5B). MDS further validate our findings by demonstrating that removing the TPR from the HH-chimeric-dimer eliminates this barrier and accommodates tighter packing of the U-boxes, which in turn leads to a thermodynamically stable symmetric dimer. The latter is in full agreement with the fCHIP crystal structure that lacks the TPR domains.
We also analyzed the critical role played by the wedge or lever action of the C-terminal segment, using both MDS and in vitro experiments. Specifically, we demonstrate that CHIP1–297–dependent substrate ubiquitination and auto-ubiquitination were significantly reduced relative to wild-type CHIP (Fig. 6). Simulations show that in the absence of the C-terminal segment, intraprotomer TPR-U-box packing is stable, rendering CHIP1–297 mostly inactive by hindering the E2 binding site. The initial stages of U-box dimerization still break the extended H7 at 153RRIH158. However, consistent with reduced helical content shown in the CHIP1–297 CD spectra (Supplementary Fig. S3), our simulations indicate that H7 breaks in both monomers of CHIP1–297. Engaged with their TPR domains, the U-boxes lack the freedom to easily rearrange into a higher affinity dimer, stalling the dimerization process around the dimer recognition state (Fig. 5). The incomplete U-box dimer should accordingly weaken the stability of the CHIP1–297 dimer, which is consistent with a shift in the thermofluor measurements and increased susceptibility to exogenous protease (Fig. 6).
Activation by dimerization and phosphorylation are vital during signal transduction and can bypass the long time scales entailed by thermodynamic control of large scale structural reorganization and/or dissociation of protein domains26. Yet, the detailed molecular mechanisms of how ATP-hydrolysis achieves these events are unclear. To our knowledge, our study represents the first unbiased full atom MDS to show how a homodimer can assemble into an asymmetric structure and generate a force to kinetically disrupt a domain-domain binding interface and activate an enzyme. The symmetry breaking pathway, which involves long helices and dimerization events common to many regulatory proteins reveals key structural transitions leading to a half-of-sites active enzyme.
Finally, we propose that asymmetry is functionally connected to CHIP autoubiquitination when substrate proteins are absent11, 27, 28, as well as to other E3 ligases with similar domain architecture. The most prominent CHIP autoubiquitination site is K2 29, 30, located within a flexible ~25-residue N-terminal segment of CHIP. Our modeling suggests that K2 of the straight (active) protomer is the only lysine that can readily access the active site of a bound E2 enzyme (not shown). Hence, the straight protomer may more likely be autoubiquitinated and targeted for degradation than the bent protomer. Another, non-mutually exclusive possibility is that asymmetry is a by-product of assembling a ubiquitin ligase. Namely, as a monomer, CHIP may block E2 binding, preventing premature CHIP degradation until a fully formed dimer is assembled. Experimental tests of these models are in progress.
Methods
A detailed description of materials and methods in given in Supplementary Information. Briefly, simulations were carried out using standard full atom MDS in explicit solvent. MDS were carried out in triplicate. Analysis of independent runs are shown in Supplementary Figures S4, S5 and S6. MD initial structures were built from available crystal structures and are available upon request. Video of representative MDS of CHIP dimerization is shown in Supplementary Video S1. Methods used for in vitro experiments including CHIP thermostability and activity measurements are described in detail in the Supplementary Information.
Electronic supplementary material
Acknowledgements
This work was funded by National Institute of Health grants 2GM097082 to C.J.C., GM75061 to J.L.B., and DK79307 (University of Pittsburgh George O’Brien Kidney Research Center). S.M. acknowledges funding support from the Johnson Cancer Research Center and Kansas State University. Z.Y. appreciates Tsinghua-Pittsburgh Joint program and Chinese Scholar Council for research opportunities and funding.
Author Contributions
S.M., J.L.B. and C.J.C. conceived the work. Z.Y. performed the simulations. P.G.N., S.K.E., S.K.W. and B.L.G. performed the biochemical experiments. Z.Y., S.M., J.L.B. and C.J.C. analyzed and interpreted the data. Z.Y., S.M., J.L.B. and C.J.C. drafted the paper.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at doi:10.1038/s41598-017-01880-4
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Blundell TL, Srinivasan N. Symmetry, stability, and dynamics of multidomain and multicomponent protein systems. Proc Natl Acad Sci USA. 1996;93:14243–14248. doi: 10.1073/pnas.93.25.14243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Koshland DE, Jr., Nemethy G, Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry. 1966;5:365–385. doi: 10.1021/bi00865a047. [DOI] [PubMed] [Google Scholar]
- 3.Seydoux F, Malhotra OP, Bernhard SA. Half-site reactivity. CRC Crit Rev Biochem. 1974;2:227–257. doi: 10.3109/10409237409105448. [DOI] [PubMed] [Google Scholar]
- 4.Nagradova NK. Interdomain interactions in oligomeric enzymes: creation of asymmetry in homo-oligomers and role in metabolite channeling between active centers of hetero-oligomers. FEBS Lett. 2001;487:327–332. doi: 10.1016/S0014-5793(00)02338-3. [DOI] [PubMed] [Google Scholar]
- 5.Wang ZX, Pan XM. Kinetic differentiation between ligand-induced and pre-existent asymmetric models. FEBS Lett. 1996;388:73–75. doi: 10.1016/0014-5793(96)00498-X. [DOI] [PubMed] [Google Scholar]
- 6.Swapna LS, Srikeerthana K, Srinivasan N. Extent of structural asymmetry in homodimeric proteins: prevalence and relevance. PLoS One. 2012;7:e36688. doi: 10.1371/journal.pone.0036688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Brown JH. Breaking symmetry in protein dimers: designs and functions. Protein Sci. 2006;15:1–13. doi: 10.1110/ps.051658406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhang M, et al. Chaperoned ubiquitylation–crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Mol. Cell. 2005;20:525–538. doi: 10.1016/j.molcel.2005.09.023. [DOI] [PubMed] [Google Scholar]
- 9.Kose S, Furuta M, Imamoto N. Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage. Cell. 2012;149:578–589. doi: 10.1016/j.cell.2012.02.058. [DOI] [PubMed] [Google Scholar]
- 10.Ballinger CA, et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol. 1999;19:4535–4545. doi: 10.1128/MCB.19.6.4535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jiang J, et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem. 2001;276:42938–42944. doi: 10.1074/jbc.M101968200. [DOI] [PubMed] [Google Scholar]
- 12.Xu Z, et al. Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. Biochemistry. 2006;45:4749–4759. doi: 10.1021/bi0601508. [DOI] [PubMed] [Google Scholar]
- 13.Connell P, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 2001;3:93–96. doi: 10.1038/35070170. [DOI] [PubMed] [Google Scholar]
- 14.Edkins AL. CHIP: a co-chaperone for degradation by the proteasome. Subcell Biochem. 2015;78:219–242. doi: 10.1007/978-3-319-11731-7_11. [DOI] [PubMed] [Google Scholar]
- 15.Yang M, et al. E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta} J Exp Med. 2011;208:2099–2112. doi: 10.1084/jem.20102667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chen Z, et al. The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity. 2013;39:272–285. doi: 10.1016/j.immuni.2013.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wen J, Luo KJ, Hu Y, Yang H, Fu JH. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients. Ann Surg Oncol. 2013;20:1668–1675. doi: 10.1245/s10434-012-2733-4. [DOI] [PubMed] [Google Scholar]
- 18.Kajiro M, et al. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol. 2009;11:312–319. doi: 10.1038/ncb1839. [DOI] [PubMed] [Google Scholar]
- 19.Maruyama T, et al. CHIP-dependent termination of MEKK2 regulates temporal ERK activation required for proper hyperosmotic response. EMBO J. 2010;29:2501–2514. doi: 10.1038/emboj.2010.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene. 2013;32:1284–1295. doi: 10.1038/onc.2012.144. [DOI] [PubMed] [Google Scholar]
- 21.Depondt C, et al. Autosomal recessive cerebellar ataxia of adult onset due to STUB1 mutations. Neurology. 2014;82:1749–1750. doi: 10.1212/WNL.0000000000000416. [DOI] [PubMed] [Google Scholar]
- 22.Miller BR, 3rd, et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput. 2012;8:3314–3321. doi: 10.1021/ct300418h. [DOI] [PubMed] [Google Scholar]
- 23.Champ PC, Camacho CJ. FastContact: a free energy scoring tool for protein-protein complex structures. Nucleic Acids Res. 2007;35:W556–560. doi: 10.1093/nar/gkm326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Narayan V, et al. Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP) Mol Cell Proteomics. 2015;14:2973–2987. doi: 10.1074/mcp.M115.051169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Nikolay R, et al. Dimerization of the human E3 ligase CHIP via a coiled-coil domain is essential for its activity. J Biol Chem. 2004;279:2673–2678. doi: 10.1074/jbc.M311112200. [DOI] [PubMed] [Google Scholar]
- 26.Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211–225. doi: 10.1016/S0092-8674(00)00114-8. [DOI] [PubMed] [Google Scholar]
- 27.Wang D, et al. Direct identification of ubiquitination sites on ubiquitin-conjugated CHIP using MALDI mass spectrometry. J Proteome Res. 2005;4:1554–1560. doi: 10.1021/pr050104e. [DOI] [PubMed] [Google Scholar]
- 28.Cliff MJ, Williams MA, Brooke-Smith J, Barford D, Ladbury JE. Molecular recognition via coupled folding and binding in a TPR domain. J Mol Biol. 2005;346:717–732. doi: 10.1016/j.jmb.2004.12.017. [DOI] [PubMed] [Google Scholar]
- 29.Scaglione KM, et al. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol Cell. 2011;43:599–612. doi: 10.1016/j.molcel.2011.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Windheim M, Peggie M, Cohen P. Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem J. 2008;409:723–729. doi: 10.1042/BJ20071338. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.